Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Neurogenesis stimulants are agents that promote or enhance the formation of new neurons in the brain, primarily in the hippocampus. These stimulants are being explored as potential therapeutic strategies for cognitive enhancement and mood disorder treatment. Examples include DMT, psilocybin (at low doses), and experimental BAX inhibitors. Unlike general CNS stimulants, which primarily affect neurotransmitter levels, neurogenesis stimulants directly influence neuron production and survival.
Various, including anti-apoptotic effects (e.g., BAX inhibition), serotonergic modulation, and neural stem cell proliferation.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neurogenesis Stimulants.